Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Bepler

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
BMC Cancer|November 28, 2002
Regular aspirin use and lung cancer riskKirsten B Moysich, Ravi J Menezes, Adrienne Ronsani, et al.
Cells|October 6, 2020
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1Niko Moses, Mu Zhang, Jheng-Yu Wu, et al.
Carcinogenesis|September 12, 2018
Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomesDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Plos One|February 23, 2012
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cellsChristopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancerMichele L Cote, Ramsi Haddad, David J Edwards, et al.
The Journal of Biological Chemistry|December 21, 2017
Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activityJheng-Yu Wu, Shengyan Xiang, Mu Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.
Current Treatment Options in Oncology|December 4, 2010
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatmentNagi B Kumar, Aslam Kazi, Tiffany Smith, et al.
The Journal of Biological Chemistry|February 17, 2019
HDAC6 regulates DNA damage response via deacetylating MLH1Mu Zhang, Chen Hu, Niko Moses, et al.
Seminars in Oncology|August 15, 2003
Targeted therapy in combination with gemcitabine in non-small cell lung cancerRafael Rosell, Lucio Crino, Kathleen Danenberg, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
BMC Cancer|November 28, 2002
Regular aspirin use and lung cancer riskKirsten B Moysich, Ravi J Menezes, Adrienne Ronsani, et al.
Cells|October 6, 2020
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1Niko Moses, Mu Zhang, Jheng-Yu Wu, et al.
Carcinogenesis|September 12, 2018
Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomesDonovan Watza, Christine M Lusk, Gregory Dyson, et al.
Plos One|February 23, 2012
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cellsChristopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancerMichele L Cote, Ramsi Haddad, David J Edwards, et al.
The Journal of Biological Chemistry|December 21, 2017
Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activityJheng-Yu Wu, Shengyan Xiang, Mu Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2004
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerBrandon A Howard, Zhong Zheng, Michael J Campa, et al.
Current Treatment Options in Oncology|December 4, 2010
Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatmentNagi B Kumar, Aslam Kazi, Tiffany Smith, et al.
The Journal of Biological Chemistry|February 17, 2019
HDAC6 regulates DNA damage response via deacetylating MLH1Mu Zhang, Chen Hu, Niko Moses, et al.
Seminars in Oncology|August 15, 2003
Targeted therapy in combination with gemcitabine in non-small cell lung cancerRafael Rosell, Lucio Crino, Kathleen Danenberg, et al.
Pageof 16